These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27692098)

  • 41. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
    Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of matrix metalloproteinases and their tissue inhibitors as potential biomarkers of left ventricular remodelling in the athlete's heart.
    Vianello A; Caponi L; Franzoni F; Galetta F; Rossi M; Taddei M; Malvaldi G; Pietrini P; Santoro G
    Clin Sci (Lond); 2009 Jul; 117(4):157-64. PubMed ID: 19196241
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Matrix metalloproteinases and soluble Fas/FasL system as novel regulators of apoptosis in children and young adults on chronic dialysis.
    Musiał K; Zwolińska D
    Apoptosis; 2011 Jul; 16(7):653-9. PubMed ID: 21516345
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Correlation between tumor necrosis factor alpha and matrix metalloproteinases levels in serum of patients with rheumatic arthritis].
    Klimiuk PA; Sierakowski S; Chwiećko J
    Pol Merkur Lekarski; 2003 May; 14(83):410-2. PubMed ID: 12939814
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunoglobulin M-enriched human intravenous immunoglobulins reduce leukocyte-endothelial cell interactions and attenuate microvascular perfusion failure in normotensive endotoxemia.
    Hoffman JN; Fertmann JM; Vollmar B; Laschke MW; Jauch KW; Menger MD
    Shock; 2008 Jan; 29(1):133-9. PubMed ID: 18246604
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proteolytic imbalance is reversed after therapeutic surgery in breast cancer patients.
    Giannelli G; Erriquez R; Fransvea E; Daniele A; Trerotoli P; Schittulli F; Grano M; Quaranta M; Antonaci S
    Int J Cancer; 2004 May; 109(5):782-5. PubMed ID: 14999790
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression and functional properties of antibodies to tissue inhibitors of metalloproteinases (TIMPs) in rheumatoid arthritis.
    Bokarewa M; Dahlberg L; Tarkowski A
    Arthritis Res Ther; 2005; 7(5):R1014-22. PubMed ID: 16207317
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Matrix metalloproteinases and their tissue inhibitors in children and young adults on chronic hemodialysis--preliminary results].
    Musiał K; Makulska I; Zwolńska D
    Pol Merkur Lekarski; 2009 Apr; 26(154):290-3. PubMed ID: 19580190
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circulating matrix metalloproteinases and their inhibitors in patients with Kawasaki disease.
    Senzaki H; Masutani S; Kobayashi J; Kobayashi T; Nakano H; Nagasaka H; Sasaki N; Asano H; Kyo S; Yokote Y
    Circulation; 2001 Aug; 104(8):860-3. PubMed ID: 11514369
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Upregulated expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in BALB/c mouse brain challenged with Japanese encephalitis virus.
    Shukla V; Kumar Shakya A; Dhole TN; Misra UK
    Neuroimmunomodulation; 2012; 19(4):241-54. PubMed ID: 22441541
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with moderate and severe traumatic brain injury.
    Zheng K; Li C; Shan X; Liu H; Fan W; Wang Z; Zheng P
    Neurol India; 2013; 61(6):606-9. PubMed ID: 24441327
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dynamic expression of matrix metalloproteinases (MMP-2, -9 and -14) and the tissue inhibitors of MMPs (TIMP-1, -2 and -3) at the implantation site during tubal pregnancy.
    Bai SX; Wang YL; Qin L; Xiao ZJ; Herva R; Piao YS
    Reproduction; 2005 Jan; 129(1):103-13. PubMed ID: 15615902
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of serum matrix metalloproteinases as biomarkers for detection of neurological symptoms in carotid artery disease.
    Heider P; Pelisek J; Poppert H; Eckstein HH
    Vasc Endovascular Surg; 2009 Dec; 43(6):551-60. PubMed ID: 19640916
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in the serum of patients with autoimmune diseases: association with age and disease activity.
    Ziouti N; Vynios DH; Aletras AJ; Kyriakopoulou D; Mastorakou A; Andonopoulos A
    Clin Chem Lab Med; 2004; 42(8):880-8. PubMed ID: 15387437
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circulating matrix metalloproteinases and their inhibitors in premature coronary atherosclerosis.
    Noji Y; Kajinami K; Kawashiri MA; Todo Y; Horita T; Nohara A; Higashikata T; Inazu A; Koizumi J; Takegoshi T; Mabuchi H
    Clin Chem Lab Med; 2001 May; 39(5):380-4. PubMed ID: 11434385
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of localized versus systemic levels of Matrix metalloproteinases (MMPs), its tissue inhibitors (TIMPs) and cytokines in tuberculous and non-tuberculous pleuritis patients.
    Sundararajan S; Babu S; Das SD
    Hum Immunol; 2012 Oct; 73(10):985-91. PubMed ID: 22820625
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phase-dependent expression of matrix metalloproteinases and their inhibitors in demyelinating canine distemper encephalitis.
    Miao Q; Baumgärtner W; Failing K; Alldinger S
    Acta Neuropathol; 2003 Nov; 106(5):486-94. PubMed ID: 12920537
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential expression profiling of matrix metalloproteinases and tissue inhibitors of metalloproteinases in females with or without pelvic organ prolapse.
    Wang X; Li Y; Chen J; Guo X; Guan H; Li C
    Mol Med Rep; 2014 Oct; 10(4):2004-8. PubMed ID: 25110112
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of matrix metalloproteinases and tissue inhibitors of metalloproteinases in aqueous humor of dogs with versus without naturally occurring primary angle-closure glaucoma.
    Pumphrey SA; Zitek-Morrison E; Pizzirani S; Meola DM
    Am J Vet Res; 2021 Dec; 83(3):245-255. PubMed ID: 34936570
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort.
    Todd JL; Vinisko R; Liu Y; Neely ML; Overton R; Flaherty KR; Noth I; Newby LK; Lasky JA; Olman MA; Hesslinger C; Leonard TB; Palmer SM; Belperio JA;
    BMC Pulm Med; 2020 Mar; 20(1):64. PubMed ID: 32171287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.